Brown D L
Department of Anesthesiology, Virginia Mason Medical Center, Seattle, WA 98111.
Reg Anesth. 1989 Mar-Apr;14(2):63-5.
Neurolytic celiac plexus block (NCPB) has been reported to be an effective method for pain relief for a variety of intra-abdominal malignancies, especially pancreatic. In spite of this, few data exist concerning efficacy of the block for pain related to other intraabdominal tumors. The author analyzed the quality of pain relief obtained and complications during the use of NCPB in 66 patients with nonpancreatic intraabdominal malignancies. Seventy-three percent of the patients with nonpancreatic cancer pain had good pain relief, which in 59% of cases lasted through the remaining life of the patients. The incidence of neurologic injury (footdrop) was less than 0.5%. This therapy deserves more widespread use in patients with abdominal pain secondary to a variety of other malignancies, in addition to that of the pancreas.
据报道，腹腔神经丛阻滞术（NCPB）是缓解各种腹腔内恶性肿瘤（尤其是胰腺癌）疼痛的有效方法。尽管如此，关于该阻滞术对其他腹腔内肿瘤相关疼痛疗效的数据却很少。作者分析了66例非胰腺腹腔内恶性肿瘤患者在使用NCPB期间的疼痛缓解质量和并发症情况。73%的非胰腺癌疼痛患者疼痛得到了良好缓解，其中59%的病例疼痛缓解持续到患者生命终结。神经损伤（足下垂）的发生率低于0.5%。除胰腺癌外，这种治疗方法在因其他各种恶性肿瘤继发腹痛的患者中也值得更广泛地应用。
